You are here

  • Home
  • Archive
  • Volume 16, Issue Suppl 3
  • 0003: Gemcitabine-Paclitaxel-Carboplatin (TCG) VS. Paclitaxel-Carboplatin (TC) in Ovarian Cancer (OC): A Randomized Phase III Gcig Study (AGOOVAR-9, GINECO-TCG, NSGO-OC-0102)

Article Text

Article menu
Download PDFPDF
ABSTRACT: Free Communications: Ovarian Cancer Saturday, October 14, 2006
0003: Gemcitabine-Paclitaxel-Carboplatin (TCG) VS. Paclitaxel-Carboplatin (TC) in Ovarian Cancer (OC): A Randomized Phase III Gcig Study (AGOOVAR-9, GINECO-TCG, NSGO-OC-0102)

https://doi.org/10.1136/ijgc-00009577-200610001-00003

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    PDF extract preview

    This is a PDF-only article. The first page of the PDF of this article appears above.